Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-10-21 21:08:09
Reporting Period:
Accepted Time:
2020-10-21 21:08:09
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1323113 Jr N Daniel Swisher C/o Corcept Therapeutics Incorporated
149 Commonwealth Drive
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-19 5,000 $6.55 5,000 No 4 M Direct
Common Stock Disposition 2020-10-19 5,000 $17.66 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-19 5,000 $0.00 5,000 $6.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,000 2025-06-18 No 4 M Direct
  1. The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $17.51 to $17.96 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.
  3. Fully exercisable.